New antibiotics for skin infections get seal of approval from European Medicines Agency Three new antibiotics to treat serious skin infections have been recommended for approval by the European Medicines Agency.…
EMA recommends suspending licences for 700 drugs over flawed analyses by GVK BiosciencesThe European Medicines Agency is recommending that the marketing authorisation be suspended for more than 700 generic products tested by GVK Biosciences.…
EMA recommends approval of liraglutide as weight loss drugThe European Medicines Agency is recommending that the prescription-only injectable drug liraglutide (Saxenda) should be granted a marketing authorisation as a weight loss product.…
Searching social networks to detect adverse reactions Regulators and pharmaceutical companies are monitoring social media posts for potential adverse drug reaction signals.…
Safinamide recommended for approval as Parkinson’s disease therapy A new medicine that allows Parkinson’s disease patients to spend more of the day symptom-free has been recommended for approval in Europe.…
2014: The Pharmaceutical Journal’s news in review Looking back at some of the biggest news stories from the past year. …
E-cigarettes can be effective smoking cessation aids, Cochrane review suggests E-cigarettes that contain nicotine can help people quit smoking long-term or reduce the number of cigarettes they smoke compared with products that do not contain nicotine, say Cochrane reviewers.…
Initial Fluad investigations find no manufacturing defectPreliminary investigations have found no manufacturing defect in the influenza vaccine Fluad, which has been linked to the deaths of 13 older people in Italy.…
Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocytic leukaemia Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocytic leukaemia.…
Medicines regulator amends conflict of interest rules to ensure suitability of experts The European Medicines Agency has amended its policy on handling declarations of interest to ensure pharmaceutical experts are not unduly excluded.…